Health Services Research Spending and Healthcare System Impact; Comment on “Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal”

Document Type : Commentary


1 Centre for Health Services and Policy Research and School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

2 Centre for Clinical Epidemiology & Evaluation and School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada


The challenges associated with translating health services and policy research (HSPR) evidence into practice are many and long-standing. Indeed, those challenges have themselves spawned new areas of research, including knowledge translation and implementation science. These sub-disciplines have increased our understanding of the critical success factors associated with the uptake of research evidence into (system) practice. Engaging those for whom research evidence is likely to help solve implementation and/or policy problems, and ensuring that they are key partners throughout the research life-cycle, appear to us (based on current evidence) to be the most direct and effective paths to improved knowledge translation. In that regard, building on Canada’s recent Strategy for Patient Oriented Research (SPOR) would seem to offer considerable promise. The “modest” proposals offered by Thakkar and Sullivan seem less likely to bear fruit.


Main Subjects

  1. Thakkar V, Sullivan T. Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal. Int J Heal Policy Manag. 2017; forthcoming. doi:10.15171/ijhpm.2017.45.
  2. Bevan G, Karanikolos M, Exley J, Nolte E, Connolly S, Mays N. The Four Health Systems of the United Kingdom: How Do They Compare? London: the Health Foundation and Nuffield Trust; 2014.
  3. Institute for Healthcare Improvement. The IHI Triple Aim. Cambridge (MA): Institue for Healthcare Improvement; 2017.
  4. Bryant-Lukosius D, Cosby R, Bakker D, Earle C, Fitzgerald B, Burkoski V. Effective Use of Advanced Practice Nurses in the Delivery of Adult Cancer Services in Ontario. Toronto (ON): Cancer Care Ontario; May 11, 2015. Program in Evidence-based Care Guildeline No.16-4.
  5. Donald F, Martin-Misener R, Carter N, et al. A systematic review of the effectiveness of advanced practice nurses in long-term care. J Adv Nurs. 2013;69(10):2148-2161. doi:10.1111/jan.12140
  6. Martin-Misener R, Harbman P, Donald F, et al. Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: systematic review. BMJ Open. 2015;5(6):e007167. doi:10.1136/bmjopen-2014-007167
  7. Law MR, Cheng L, Dhalla IA, Heard D, Morgan SG. The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012;184(3):297-302. doi:10.1503/cmaj.111270
  8. Morgan S, Law M, Daw J, Abraham L. Estimated cost of universal public coverage of prescription drugs in Canada. CMAJ. 2015;187(7):491-497. doi:10.1503/cmaj.141564
  9. Shortell SM, Schmittdiel J, Wang MC, et al. An empirical assessment of high-performing medical groups: results from a national study. Med Care Res Rev. 2005;62(4):407-434. doi:10.1177/1077558705277389
  10. Mannion R, Davies HT, Marshall MN. Cultural characteristics of “high” and “low” performing hospitals. J Health Organ Manag. 2005;19(6):431-439. doi:10.1108/14777260510629689
  11. Hogg WE, Wodchis WP, Katz A, Wong ST, Cullen R, Yelland G. Bringing Canada together. Can Fam Physician. 2015;61(5):403-405.
  12. Buxton M, Hanney S. How can payback for health services research be assessed? J Health Serv Res Policy. 1996;1(1):35-43. doi:10.1177/135581969600100107
  13. Canadian Academy of Health Sciences. Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research Report. Ottawa, ON; 2009.
  14. Lavis JN, Robertson D, Woodside JM, McLeod CB, Abelson J. How can research organizations more effectively transfer research knowledge to decision makers? Milbank Q. 2003;81(2):221-248. doi:10.1111/1468-0009.t01-1-00052
  15. Law MR, Kratzer J. The road to competitive generic drug prices in Canada. CMAJ. 2013;185(13):1141-1144. doi:10.1503/cmaj.121367.
  16. Martens PJ, Bowen S, Fransoo R. KT in action: Manitoba’s the need to know team. Ottawa (ON): Canadian Institutes of Health Research; 2006.
  17. Barr N, Vania D, Randall G, Mulvale G. Impact of information and communicaton technology on interprofessional collaboration for chronic disease management: a systematic review. J Health Serv Res Policy. 2017; Forthcoming. doi:10.1177/1355819617714292
  18. Van Hasselt M, McCall N, Keyes V, Wensky SG, Smith KW. Total cost of care lower among medicare fee-for-service beneficiaries receiving care from patient-centered medical homes. Health Serv Res. 2015;50(1):253-272. doi:10.1111/1475-6773.12217
  19. Lomas J. Using “linkage and exchange” to move research into policy at a Canadian foundation. Health Aff (Millwood). 2000;19(3):236-240. doi:10.1377/hlthaff.19.3.236.
  20. Kitson A, Bisby M. Speeding up the spread: Putting KT research into practice and developing an integrated KT collaborative research agenda. Edmonton (AB): Alberta Heritage Medical Foundation; 2008.
  21. Canadian Institutes of Health Research. Guide to Knowledge Translation Planning at CIHR: Integrated and End-of-Grant Approaches. Ottawa (ON): Canadian Institutes of Health Research; 2012.